PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Hamad Medical Corporation, Doha, Qatar; Weil Cornell Medical College, New York, NY and Doha, Qatar.\', \'Microbiology and Immunology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.\', \'Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.\', \'Hamad Medical Corporation, Doha, Qatar.\', \'Ministry of Public Health, Qatar.\', \'Weil Cornell Medical College, New York, NY and Doha, Qatar; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(21)00639-110.1016/j.ijid.2021.08.008
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 34375762
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all